Laminaran potentiates cGAS-STING signaling to enhance antiviral responses
International Immunopharmacology · 2025-02 · 147 · 114014
DOI: 10.1016/j.intimp.2025.114014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-02. Verfasst von Lingxiao Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China; Department of …. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Cyclic GMP-AMP synthase (cGAS)-Stimulator of interferon genes (STING) signaling pathway, an essential element in the innate antiviral immune responses, has emerged as a key component of innate immune system to modulate type I IFNs production and response by recognizing both exogenous and endogenous DNA. Although some cGAS-STING signaling small molecule agonists have been developed, there are few natural polysaccharides reported to activate cGAS-STING signaling for the treatment of infectious diseases. Here, we reported that Laminaran, a low molecular weight β-glucan storage polysaccharide present in brown algae, potentiates cGAS-STING signaling to promote type I IFNs production and antiviral response. Laminaran enhanced cGAS-STING signaling mediated type I IFNs production and response both in human and murine cells upon HSV-1 infection or DNA mimics stimulation. Importantly, we found that Laminaran markedly inhibited Herpes simplex virus-1 (HSV-1) induced death and inflammatory responses and increased the induction of type I IFNs in C57BL/6J mice. Mechanistically, we found Laminaran inhibited autophagy and suppressed STING autophagic degradation to positively regulate cGAS-STING signaling response. Taken together, we uncovered the function of Laminaran in DNA triggered innate immunity by enhancing cGAS-STING signaling response. Laminaran might be a potential therapeutic candidate for viral infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical Univers…
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
- Guangdong Provincial Key Laboratory of Speed Capability Research, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
- Department of Emergency Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Biomedical Science, City University of Hong Kong, Kowloon, Hong Kong, China.
- State Key Laboratory for Macromolecule Drugs and Large-scale Preparation, Department of Pharmacology, Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Xu, L., Lyu, J., Qiu, Z., Liu, Q., Hu, H., Zhao, L., & Pan, M. (2025). Laminaran potentiates cGAS-STING signaling to enhance antiviral responses. International Immunopharmacology, 147, 114014. https://doi.org/10.1016/j.intimp.2025.114014
Vancouver
Xu L, Lyu J, Qiu Z, Liu Q, Hu H, Zhao L, et al. Laminaran potentiates cGAS-STING signaling to enhance antiviral responses. International Immunopharmacology. 2025;147:114014. doi:10.1016/j.intimp.2025.114014
BibTeX
@article{Xu2025,
author = {Xu, Lingxiao and Lyu, Jiao and Qiu, Zuocheng and Liu, Qianghui and Hu, Huan and Zhao, Longwei and Pan, Mingyu},
title = {Laminaran potentiates cGAS-STING signaling to enhance antiviral responses},
journal = {International Immunopharmacology},
year = {2025},
volume = {147},
pages = {114014},
doi = {10.1016/j.intimp.2025.114014}
}
EUVIMED